1. Home
  2. PR vs DGX Comparison

PR vs DGX Comparison

Compare PR & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Permian Resources Corporation

PR

Permian Resources Corporation

N/A

Current Price

$23.83

Market Cap

19.5B

Sector

Energy

ML Signal

N/A

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

N/A

Current Price

$240.67

Market Cap

23.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PR
DGX
Founded
2015
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5B
23.2B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
PR
DGX
Price
$23.83
$240.67
Analyst Decision
Buy
Buy
Analyst Count
19
13
Target Price
$22.35
$214.38
AVG Volume (30 Days)
9.7M
749.7K
Earning Date
05-06-2026
04-21-2026
Dividend Yield
2.96%
1.82%
EPS Growth
N/A
13.78
EPS
0.99
5.08
Revenue
$5,065,211,000.00
$11,035,000,000.00
Revenue This Year
$20.94
$7.53
Revenue Next Year
$7.51
$3.77
P/E Ratio
$24.03
$46.50
Revenue Growth
1.29
11.78
52 Week Low
$11.92
$171.18
52 Week High
$24.09
$247.19

Technical Indicators

Market Signals
Indicator
PR
DGX
Relative Strength Index (RSI) 65.18 58.67
Support Level $19.34 $190.40
Resistance Level $24.09 N/A
Average True Range (ATR) 0.60 4.69
MACD 0.03 -1.26
Stochastic Oscillator 92.56 53.74

Price Performance

Historical Comparison
PR
DGX

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization, and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: